<DOC>
	<DOCNO>NCT01467583</DOCNO>
	<brief_summary>The primary objective study determine whether dose-adjusted prophylaxis fondaparinux regimen 2.5 milligram ( mg ) subcutaneously administer every ( q ) 48 hour ( hr ) patient renal failure achieve peak trough level similar patient normal renal function , protect patient develop venous thromboembolism ( VTE ) . Our hypothesis dose-adjusted fondaparinux regimen , extend dose interval q24 q48 hr , patient estimate creatinine clearance &lt; 30 ml/min , safe effective .</brief_summary>
	<brief_title>Fondaparinux Critically Ill Patients With Renal Failure</brief_title>
	<detailed_description>We study fondaparinux 2.5 mg subcutaneously every 48 hr three distinct patient group : 1 ) Acute kidney failure without hemodialysis , 2 ) Acute kidney failure ( AKI ) intermittent hemodialysis ( IHD ) 3 ) Acute renal failure continuous renal replacement therapy ( CRRT ) . All patient assess efficacy dose . Efficacy assess follow clinically evidence VTE , either deep venous thrombosis ( DVT ) pulmonary embolism . In addition , low extremity duplex study perform baseline end study period ass DVT . Secondary objective safety accumulation . Safety determine assessment clinically significant bleeding , define drop Hgb &gt; 2 gram ( gm ) 24 hr , need red blood cell transfusion relate bleeding . Accumulation may occur renal failure study throughout intensive care unit ( ICU ) stay reevaluation level time .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<criteria>1 . Age ≥ 18 year old ≤ 89 year old 2 . Body weight ≥ 50 kg ≤ 150 kg 3 . Estimated creatinine clearance &lt; 30 mL/min 4 . Predicted ICU stay 72 hour . 1 . Pregnant woman 2 . Infective Endocarditis 3 . Neuraxial anesthesia spinal puncture 4 . Active bleed 5 . Treatment vitamin K antagonists therapeutic dos unfractionated heparin 6 . Signs disseminate intravascular coagulation 7 . Severe liver failure ( serum bilirubin &gt; 5 mg/dL ) 8 . Surgery plan within 24 hour ICU admission 9 . Latex allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Fondaparinux</keyword>
	<keyword>Renal Failure</keyword>
	<keyword>Critically Ill</keyword>
</DOC>